Comorbid Substance Use
Presented By:
Dr Didier Jutras-Aswad and Dr David Crockford
Learning Objectives:
-
Know the current epidemiology for methamphetamine use
-
Differentiate methamphetamine induced psychosis from a primary psychotic disorder
-
Manage methamphetamine induced psychosis
-
Discuss the relevance of approaches to decrease risk of cannabis-related harms in people with psychosis
-
Know about existing initiatives and tools aimed at reducing cannabis-related risk of harms
-
Apply some strategies to decrease risk of cannabis-related harms in people with psychosis
Originally Presented at the 2024 EPI Canada Conference
This initiative has been sponsored in part by AbbVie, Boehringer Ingelheim, HLS Therapeutics Inc, Janssen, Otsuka-Lundbeck Alliance, and Teva through educational grants.